Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Obstacles to the expansion of cells with proliferative potential include the induction of cell death, telomere-based senescence, and the pRb and p53 tumor suppressors. Not infrequently, the molecular pathways regulating oncogenesis recapitulate aberrations of processes governing embryogenesis. The genetic network, consisting of the dachshund (dac), eyes absent (eya), eyeless, and sine oculis (so) genes, regulates cell fate determination in metazoans, with dac serving as a cointegrator through a So DNA-binding factor. Here,
DACH1
inhibited oncogene-mediated breast oncogenesis, blocking breast cancer epithelial cell DNA synthesis, colony formation, growth in Matrigel, and tumor growth in mice. Genetic deletion studies demonstrated a requirement for cyclin D1 in
DACH1
-mediated inhibition of DNA synthesis.
DACH1
repressed cyclin D1 through a novel mechanism via a
c-Jun
DNA-binding partner, requiring the
DACH1
alpha-helical DS domain which recruits corepressors to the local chromatin. Analysis of over 2,000 patients demonstrated increased nuclear
DACH1
expression correlated inversely with cellular mitosis and predicted improved breast cancer patient survival. The cell fate determination factor,
DACH1
, arrests breast tumor proliferation and growth in vivo providing a new mechanistic and potential therapeutic insight into this common disease.
...
PMID:DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. 1698 Jun 15
The cell fate determination factor
DACH1
plays a key role in cellular differentiation in metazoans.
DACH1
is engaged in multiple context-dependent complexes that activate or repress transcription.
DACH1
can be recruited to DNA via the Six1/Eya bipartite transcription (DNA binding/coactivator) complex.
c-Jun
is a critical component of the activator protein (AP)-1 transcription factor complex and can promote contact-independent growth. Herein,
DACH1
inhibited
c-Jun
-induced DNA synthesis and cellular proliferation. Excision of
c-Jun
with Cre recombinase, in c-jun(f1/f1) 3T3 cells, abrogated
DACH1
-mediated inhibition of DNA synthesis.
c-Jun
expression rescued
DACH1
-mediated inhibition of cellular proliferation.
DACH1
inhibited induction of
c-Jun
by physiological stimuli and repressed c-jun target genes (cyclin A, beta-PAK, and stathmin).
DACH1
bound
c-Jun
and inhibited AP-1 transcriptional activity. c-jun and c-fos were transcriptionally repressed by
DACH1
, requiring the conserved N-terminal (dac and ski/sno [DS]) domain. c-fos transcriptional repression by
DACH1
requires the SRF site of the c-fos promoter.
DACH1
inhibited
c-Jun
transactivation through the delta domain of
c-Jun
.
DACH1
coprecipitated the histone deacetylase proteins (HDAC1, HDAC2, and NCoR), providing a mechanism by which
DACH1
represses
c-Jun
activity through the conserved delta domain. An oncogenic v-Jun deleted of the delta domain was resistant to
DACH1
repression. Collectively, these studies demonstrate a novel mechanism by which
DACH1
blocks
c-Jun
-mediated contact-independent growth through repressing the
c-Jun
delta domain.
...
PMID:Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. 1718 46